| Literature DB >> 32161098 |
David M Stepien1, Charles Hwang1, Simone Marini2, Chase A Pagani1, Michael Sorkin1, Noelle D Visser1, Amanda K Huber1, Nicole J Edwards1, Shawn J Loder1, Kaetlin Vasquez1, Carlos A Aguilar1,3, Ravi Kumar4, Shamik Mascharak5, Michael T Longaker5,6, Jun Li2, Benjamin Levi7.
Abstract
Myeloid cells are critical to the development of fibrosis following muscle injury; however, the mechanism of their role in fibrosis formation remains unclear. In this study, we demonstrate that myeloid cell-derived TGF-β1 signaling is increased in a profibrotic ischemia reperfusion and cardiotoxin muscle injury model. We found that myeloid-specific deletion of Tgfb1 abrogates the fibrotic response in this injury model and reduces fibro/adipogenic progenitor cell proliferation while simultaneously enhancing muscle regeneration, which is abrogated by adaptive transfer of normal macrophages. Similarly, a murine TGFBRII-Fc ligand trap administered after injury significantly reduced muscle fibrosis and improved muscle regeneration. This study ultimately demonstrates that infiltrating myeloid cell TGF-β1 is responsible for the development of traumatic muscle fibrosis, and its blockade offers a promising therapeutic target for preventing muscle fibrosis after ischemic injury.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32161098 PMCID: PMC8080967 DOI: 10.4049/jimmunol.1900814
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422